Article

Global Access Program

RMD_Virology_Global Access Program_Hero

Working hand in hand to enable sustainable access to world-class diagnostics for the people who need them, when they need them – no matter where they live.

Take Aim Stop Disease
Universal access to quality healthcare and medical innovation remains a global challenge.
 

In resource-limited regions, the need for reliable and sustainable healthcare and its supporting infrastructure is crucial in the fight against disease and advancing human health.

Recognising that diagnostics is an integral component for functioning health systems, in 2014 Roche launched the Global Access Program to enable access to reliable testing solutions for patients in low- and low-middle income countries (LMICs). Our goal is to use innovative solutions and leverage world-class expertise to establish diagnostics as a frontline defence against diseases such as HIV/AIDs, Tuberculosis (TB), Hepatitis B and C (HBV and HCV), COVID-19 and Human Papillomavirus (HPV)/ Cervical cancer.

By working together with international agencies, non-governmental organizations and governments at the global, regional and local level, we take a holistic and collaborative approach to improve health system diagnostic capacity.

 Join the leading provider of HIV viral load testing as it expands access to diagnostic testing for countries hardest hit by HIV.
Take aim at tuberculosis. The leading killer of HIV-positive people, Roche is committed to working towards the WHO road map to stop this challenging infection.
Making screening for high-risk HPV available to women in greatest need.
Hepatitis B and C are among the most common viral infections in the world. At least 263 million worldwide in 2017 – are carriers of hepatitis B or C virus infections, which can remain asymptomatic for decades.
...
    ...
    Our range of solutions includes disease awareness and education programs, healthcare worker training, lab efficiency consulting and digital solutions. Through our partnerships we can help create scalable and sustainable solutions for laboratories, healthcare professionals and patients.

     

    Our aim is to support international agencies and countries with a long term goal of establishing sustainable national programs.
    PSC

    Innovation in HIV testing

    Redefine the reach of reliable testing. Making quantitative HIV viral load testing more accessible to those in remote areas.1   

    Explore
    Redefining access through innovative solutions
     

    There are many barriers to accessing reliable diagnostics, proper treatment and care. In resource-limited settings, affordability is often a challenge. Through the Global Access Program, Roche provides sustainable pricing to governments and funders in eligible countries, alongside working with partners to deliver comprehensive solutions along the patient pathway.

    In addition we develop innovative solutions specifically for challenges in LMICs. These include devices that simplify sample collection and transportation for reliable testing in rural settings and digital tools that empower patients to remain adherent to treatment and engaged in care.

    test

    Roche Diagnostics joins force with nonprofit (RED) organization

    Together, as a community, we can emphasize the importance of diagnostic testing as a critical step to reach the goal of an AIDS-free generation by 2030. Meeting UNAIDS elimination goals1 is impossible without testing.

    GAP Infographic

    What you need to know about the Global Access Program

    Get a visual overview of the GAP landscape
    Download
    Optimising resource efficiency
     

    Roche instruments have the capacity to test across multiple disease areas, making our solutions more resource efficient. This benefits national testing programs by testing more people, across more disease areas, in the most timely and cost-effective way.

    Through a more integrated testing approach and network optimisation of diagnostic labs, it is possible to leverage strengths of different testing technologies and provide innovative solutions to build strong sample referral networks and ensure result return to reduce loss to follow up. By bringing together resource efficiency and physical accessibility in this way, we are able to provide access to diagnostics than ever before.

    Since its inception, the Global Access Program has expanded substantially to provide increased access to diagnostics at affordable pricing for resource-constrained countries. It is part of Roche’s commitment to improving sustainable access to quality healthcare solutions for the people who need them, when they need them – no matter where they live.

     Through partnerships with national governments, local healthcare facilities, communities and international agencies, the Roche Global Access Program launched in 2014 with the hopes to provide universal access to reliable HIV diagnostic tools in countries with the highest disease burden.
    In 2018, Roche and KEMRI forged a partnership for working toward the UNAIDS 90-90-90 goal. As a result, Roche has installed its state-of-the-art diagnostic instrument for HIV viral load testing at KEMRI. It has also trained KEMRI technicians on the operation of this instrument.
    HIV transmission and guidelines for screening
    ...
      ...
      GAP combination

      Resources

       

      Global Access Program Country List

      Frequently Asked Questions

      References

      1. UNAIDS Core Epidemiology Slides, July 2015. https://www.unaids.org/sites/default/files/media_asset/20150714_epi_core_en.pdf. Accessed October 11, 2023.
      2. UNAIDS Report on the global AIDS epidemic. 2010. www.unaids.org/globalreport/HIV_prevalence_map.htm. Accessed October 11, 2023.
      3. 90-90-90 An ambitious treatment target to help end the AIDS epidemic. 2014. www.unaids.org/sites/default/files/en/media/ unaids/contentassets/documents/unaidspublication/ 2014/90-90-90_en.pdf. Accessed October 11, 2023.
      4. Management of Infants Born to People with HIV Infection.  https://clinicalinfo.hiv.gov/en/guidelines/perinatal/management-infants-diagnosis-hiv-infection-children.  Accessed October 11, 2023.
      5. UNAIDS 2013 | AIDS by the numbers. www.unaids.org/sites/ default/files/media_asset/ JC2571_AIDS_by_the_numbers_en_1.pdf. Accessed October 11, 2023.